SCHEMBL4240347

SCHEMBL4240347

CC(C)(CCCNC(=O)O)CNC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
FFAR1 O14842 1/20 0.43
CPT2 P23786 1/20 0.43
EPHX1 P07099 7/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4C Q9H3R0 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
CASP2 P42575 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6730282 0.80 ALDH1A1 (0.38) TDP1FFAR1CPT2EPHX1MEN1
SCHEMBL5795037 0.78 ALDH1A1 (0.39) TDP1FFAR1CPT2MEN1KMT2A
SCHEMBL18125947 0.76 KDM4E (0.48) TDP1FFAR1CPT2SMN1; SMN2HSD17B10
SCHEMBL25357456 0.75 SMN1; SMN2 (0.37) TDP1EPHX1MEN1KMT2ASMN1; SMN2
SCHEMBL11269180 0.73 ALDH1A1 (0.30) SMN1; SMN2POLB
SCHEMBL14392982 0.73 TDP1 (0.42) TDP1FFAR1CPT2EPHX1MEN1
SCHEMBL1979548 0.73 SMN1; SMN2 (0.38) TDP1FFAR1CPT2SMN1; SMN2HSD17B10
SCHEMBL6729276 0.73 SMN1; SMN2 (0.38) TDP1FFAR1CPT2EPHX1KDM4C
SCHEMBL22854215 0.72 TDP1 (0.40) TDP1FFAR1CPT2EPHX1MEN1
SCHEMBL5620319 0.71 ALDH1A1 (0.44) EPHX1MEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558257-B1 DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE GRUENENTHAL GMBH (DE) 2013-12-25 EP claimed
EP-1515702-B1 ABUSE-PROTECTED ADMINISTRATION FORM GRUENENTHAL GMBH (DE) 2008-10-15 EP claimed
EP-1558221-B1 DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE GRUENENTHAL GMBH (DE) 2007-06-06 EP claimed
EP-1765303-B2 ORAL TABLET SAFEGUARDED AGAINST ABUSE GRUENENTHAL GMBH (DE) 2022-11-23 EP disclosed
US-8722086-B2 Dosage form with impeded abuse GRUENENTHAL GMBH (DE) 2014-05-13 US disclosed
US-20090004267-A1 Dosage Form with Impeded Abuse GRUENENTHAL GMBH (DE) 2009-01-01 US disclosed
EP-0595364-B1 Benz[e]indene derivatives and a process for preparing them as well as medicaments containing them and the use of them EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1996-07-24 EP disclosed
EP-0619299-A2 1-(Phenyl)-3-[omega-(amino)-alkoxyimino]-alk-1-ene derivatives, a process for preparing them as well as medicaments containing them and the use of them EGIS GYOGYSZERGYAR RT. (HU) 1994-10-12 EP disclosed
EP-0595364-A1 Benz[e]indene derivatives and a process for preparing them as well as medicaments containing them and the use of them EGIS GYOGYSZERGYAR RT. (HU) 1994-05-04 EP disclosed